Inhibition of sulfotransferases by xenobiotics

Current Drug Metabolism

Volumn 7, Issue 1, 2006, Pages 83-104

  Wang, Li Quan ^a   James, Margaret O ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Inhibition; Inhibitors; Sulfonation (sulfation); Sulfotransferases; Xenobiotics

Indexed keywords

2,6 DICHLORO 4 NITROPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; AMINE; AROMATIC HYDROCARBON; CATECHIN; CLOMIFENE; CYCLIZINE; DAIDZEIN; DANAZOL; ESTRADIOL; FLAVONOID; FOOD DYE; GENISTEIN; HYDROXYL GROUP; ISOENZYME; MEFENAMIC ACID; NEUROTRANSMITTER; PENTACHLOROPHENOL; PHYTOESTROGEN; POLYCHLORINATED BIPHENYL; QUERCETIN; SALICYLIC ACID; SPIRONOLACTONE; STEROID; SULFOTRANSFERASE; THYROID HORMONE; TRICLOSAN; UNINDEXED DRUG; XENOBIOTIC AGENT; DRUG; ENZYME INHIBITOR;

AMINO ACID SEQUENCE; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONJUGATION; DETOXIFICATION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; EXPOSURE; FOOD COMPOSITION; GENOTOXICITY; HORMONE TRANSPORT; HUMAN; HYDROXYLATION; INHIBITION KINETICS; LIVER CANCER; MOUSE; NONHUMAN; PROTEIN FAMILY; RAT; RED WINE; REVIEW; SCIENTIFIC LITERATURE; SULFATION; SULFONATION; ANIMAL; CHEMISTRY; CLASSIFICATION; DRUG ANTAGONISM; KINETICS; NOMENCLATURE; POLLUTANT;

ANIMALS; ENVIRONMENTAL POLLUTANTS; ENZYME INHIBITORS; HUMANS; KINETICS; PHARMACEUTICAL PREPARATIONS; SULFOTRANSFERASES; TERMINOLOGY; XENOBIOTICS;

EID: 30944444047     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920006774832596     Document Type: Review

References (206)

1. Mulder, G.J. and Jakoby, W.B. (1990) In Conjugation Reactions in Drug Metabolism: An Integrated Approach (Mulder, G.G. Ed), Taylor & Francis, London, pp. 107-161.
2. Weinshilboum, R.M. (1986) Fed. Proc., 45, 2223-2228.
3. Falany, C.N. (1991) Trends Pharmcol. Sci., 12, 255-259.
4. Coughtrie, M.W.H.; Sharp, S.; Maxwell, K. and Innes, I.P. (1998) Chem. Biol. Interact, 109, 3-27.
5. Meerman, J.H.N. and Vandepoll, M.L.M. (1994) Environ. Health Perspect., 102, 153-159.
6. Chou, H.-C.; Lang, N.P. and Kadlubar, F.F. (1995) Cancer Res., 55, 525-529.
7. Kato, R. and Yamazoe, Y. (1994) Drug Metab. Rev., 26, 413-430.
8. Gilissen, R.A.H.J.; Hume, R.; Meerman, J.H.N. and Coughtrie, M.W.H. (1994) Biochem. Pharmacol., 48, 837-840.
9. Surh, Y.-J. and Tannenbaum, S.R. (1994) Chem. Res. Toxicol., 7, 313-318.
10. Robertson, H.A. and King, G.J. (1979) J. Reprod Fertil., 55, 463-470.
11. Loriaux, D.; Ruder, H. and Lipsett, M. (1971) Steroids, 18, 463-473.
12. Baulieu, E.E. (1996) J. Clin. Endocrinol. Metab., 81, 3147-3151.
13. Plager, J.E. (1965) J. Clin. Invest., 44, 1234-1239.
14. Martel, C.; Melner, M.H.; Gagne, D.; Simard, J. and Labrie, F. (1994) Mol Cell Endocrinol., 104, 103-111.
15. Dooley, T.P.; Haldeman-Cahill. R.; Joiner, J. and Wilborn, T.W. (2000) Biochem. Biophys. Res. Commun., 277, 236-245.
16. Morato, T.; Lemus, A.E. and Gaul, C. (1965) Steroids (suppl. 1), 5, 59.
17. Hobkirk, R. (1985) Can. J. Biochem. Cell Biol., 63, 1127-1144.
18. Mortola, J.F. and Yen, S.S.C. (1990) Endocrinology, 71, 696-704.
19. Kester, M.H.A.; Van Dijk, C.H.; Tibboel, D.; Hood, A.M.; Rose, N.J.M.; Meinl, W.; Pabel, U.; Glatt, H.; Falany, C.N.; Coughtrie, M.W.H. and Visser, T.J. (1999) J. Clin. Endocrinol. Metab., 84, 2577-2580.
20. Visser, T.J.; Kaptein, E.; Glatt, H.; Bartsch, I.; Hagen, M. and Coughtrie, M.W. (1998) Chem. Biol. Interact., 109, 279-291.
21. Wang, J.; Falany, J.L. and Falany, C.N. (1998) Mol. Pharmacol., 53, 274-282.
22. Coughtrie, M.W.H. (1996) Hum. Exp. Toxicol., 15, 547-555.
23. Boulton, A.A. and Eisenhofer, G. (1998) Adv. Pharmacol., 42, 273-292.
24. Konishi-Imamura, L.; Kim, D.H. and Kobashi, K. (1991) Chem. Pharm. Bull., 39, 2994-2998.
25. Kuchel, O.; Buu, N.T.; Racz, K.; DeLeon, A.; Serri, O. and Kyncl, J. (1986) Fed. Proc., 45, 2254-2259.
26. Singer, S.S. (1994) Chem. Biol. Interact., 92, 33-45.
27. McCall, J.M.; Aiken, J.W.; Chidester, C.G.; DuCharme, D.W. and Wendling, M.G. (1983) J. Med. Chem., 26, 1791-1793.
28. Buhl, A.E.; Waldon, D.J.; Baker, C.A. and Johnson, G.A. (1990) J. Invest. Dermatol., 95, 553-557.
29. Garay, R.P.; Nazaret, C. and Cragoe E.J., Jr. (1991) Eur. J. Pharmacol., 200, 141-146.
30. Mutschler, E.; Gilfrich, H.J.; Knauf, K.; Möhrke, W. and Völger, K.D. (1983) Clin. Exp. Hypertens. A, 5, 249-269.
31. Brown, C.E.; Roerig, S.C.; Burger, V.T.; Cody, R.B., Jr. and Fujimoto, J.M. (1985) J. Pharm. Sci., 74, 821-824.
32. Shukla, D.; Liu, J.; Blaiklock, P.; Shworak, N.W.; Bai, X.; Esko, J.D.; Cohen, G.H.; Eisenberg, R.J.; Rosenberg, R.D. and Spear, P.G. (1999) Cell, 99, 13-22.
33. Farzan, M.; Mirzabekov, T.; Kolchinsky, P.; Wyatt, R.; Cayabyab, M.; Gerard, N.P.; Gerard, C.; Sodroski, J. and Choe, H. (1999) Cell, 96, 667-676.
34. Cormier, E.G.; Persuh, M.; Thompson, D.A.D.; Lin, S.W.; Sakmar, T.P.; Olson, W.C. and Dragic, T. (2000) Proc. Natl. Acad. Sci. USA, 97, 5762-5767.
35. Kansas, G.S. (1996) Blood, 88, 3259-3287.
36. Pasqualini, J.R. and Chetrite, G.S. (1999) J. Steroid Biochem. Mol. Mol., 69, 287-292.
37. Otake, Y.; Nolan, A.L.; Walle, U.K. and Walle, T. (2000) J. Steroid Biochem. Mol. Biol., 73, 265-270.
38. Jones, A.L.; Roberts, R.C.; Colvin, D.W.; Rubin, G.L. and Coughtrie, M.W.H. (1995) Eur. J. Clin. Pharmacol., 49, 109-114.
39. Falany, C.N. (1997) FASEB J., 11, 206-216.
40. Banoglu, E. (2000) Curr. Drug Metab., 1, 1-30.
41. Nagata, K. and Yamazoe, Y. (2000) Annu. Rev. Pharmacol. Toxicol., 40, 159-176.
42. Glatt, H.R. (2000) Chem. Biol. Interact., 129, 141-170.
43. Negishi, M.; Pedersen, L.G.; Petrotchenko, E.; Shevtsov, S.; Gorokhov, A.; Kakuta, Y. and Pedersen, L.C. (2001) Arch. Biochem. Biophys., 390, 149-157.
44. Duffel, M.W.; Marshall, A.D.; McPhie, P.; Sharma, V. and Jakoby, W.B. (2001) Drug Metab. Rev., 33, 369-395.
45. Coughtrie, M.W.H. (2002) Pharmacogenomics J., 2, 297-308.
46. Chapman, E.; Best, M.D.; Hanson, S.R. and Wong, C.-H. (2004) Angew. Chem. Int. Ed., 43, 3526-3548.
47. Pacifici, G.M. (2004) Int. J. Clin. Pharmacol. Ther., 42:488-495.
48. Rath, V.L.; Verdugo, D. and Hemmerich, S. (2004) Drug Discov. Today, 9, 1003-1011.
49. Blanchard, R.L.; Freimuth, R.R.; Buck, J.; Weinshilboum, R.M. and Coughtrie, M.W.H. (2004) Pharmacogenetics, 14, 199-211.
50. Weinshilboum, R.M. and Otterness, D. (1994) In Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity (Kaufmann, F.C.; Ed), Springer-Verlag, Berlin, pp. 45-78.
51. Driscoll, W.J.; Komatsu, K. and Strott, C.A. (1995) Proc. Natl. Acad. Sci. USA, 92, 12328-12332.
52. Tamura, H.; Morioka, Y.; Homma, H. and Matsui, M. (1997) Arch. Biochem. Biophys., 341, 309-314.
53. Sakakibara, Y.; Takami, Y.; Nakayama, T.; Suiko, M. and Liu, M.-C. (1998) J. Biol. Chem., 273, 6242-6247.
54. Gamage, N.U.; Duggleby, R.G.; Barnett, A.C.; Tresillian M.; Latham, C.F.; Liyou, N.E.; McManus, M.E. and Martin, J.L. (2003) J. Biol. Chem., 278, 7655-7662.
55. Bidwell, L.M.; McManus, M.E.; Gaedigk, A.; Kakuta, Y.; Negishi, M.; Pedersen, L. and Martin, J.L. (1999) J. Mol. Biol., 293, 521-530.
56. Dombrovski, L.; Pegasova, T.; Wu, H.; Loppnau, P.; Edwards, A.M.; Arrowsmith, C.H.; Sundstrom, M.; Plotnikov, A.N. and Bochkarev, A. (2005) to be published. (http://www.rcsb.org/pdb/cgi/explore.cgi?pid= 246851113165708&pdbId=1XV1).
57. Shevtsov, S.; Petrotchenko, E.V.; Pedersen, L.C. and Negishi, M. (2003) Environ. Health Perspect., 111, 884-888.
58. Pedersen, L.C.; Petrotchenko, E.; Shevtsov, S. and Negishi, M. (2002) J. Biol. Chem., 277, 17928-17932.
59. Kakuta, Y.; Pedersen, L.G.; Carter, C.W.; Negishi, M. and Pedersen, L.C. (1997) Nat. Struct. Biol., 4, 904-908.
60. Pederson, L.C.; Petrochenko, E.V. and Negishi, M. (2000) FEBS Lett., 475, 61-64.
61. Rehse, P.H.; Zhou, M. and Lin, S.-X. (2002) Biochem. J., 364, 165-171.
62. Chang, H.J.; Shi, R.; Rehse, P. and Lin, S.X. (2004) J. Biol. Chem., 279, 2689-2696.
63. Lee, K.A.; Fuda, H.; Lee, Y.C.; Negishi, M.; Strott, C.A. and Pedersen, L.C. (2003) J. Biol. Chem., 278, 44593-44599.
64. Ozawa, S.; Nagata, K.; Yamazoe, Y. and Kato, R. (1995) Jpn. J. Caner Res., 86, 264-269.
65. Stillwell, W.G.; Turesky, R.J.; Gross, G.A.; Skipper, P.L. and Tannenbaum, S.R. (1994) Cancer Epidemiol Biomarkers Prevent., 3, 399-405.
66. Hähnel, R.; Twaddle, E. and Ratajczak, T. (1973) J. Steroid Biochem., 4, 21-31.
67. Lenz, T.; Werle, E.; Strobel, G. and Weicker, H. (1991) Can. J. Physiol. Pharmacol., 69, 929-937.
68. Werle, E.; Lenz, T.; Strobel, G. and Weicker, H. (1998) Naunyn-Schmiedeberg's Arch. Pharmacol., 338, 28-34.
69. Spaulding, S.W. (1994) In Thyroid hormone metabolism: Molecular biology and alternate pathways (Wu, S.Y. and Visser, T.J.; Eds), CRC Press, Boca Raton, FL, pp. 139-153.
70. Glatt, H.R. (1997) FASEB J., 11, 314-321.
71. Miller, J.A. (1994) Chem. Biol. Interact., 92, 2329-2341.
72. Wakazono, H.; Gardner, I, Eliasson, E. and Coughtrie, M.W.H. (1998) Chem. Res. Toxicol., 11, 863-872.
73. Glatt, H.R.; Bartsch, I.; Christoph, S.; Coughtrie M.W.H.; Falany, C.N.; Hagen, M.; Landsiedel, R.; Pabel, U.; Phillips, D.H.; Seidel, A. and Yamazoe, Y. (1998) Chem. Biol. Interact., 109, 195-219.
74. Glatt, H.R.; Pauly, K.; Piee-Staffa, A.; Seidel A.; Hornhardt, S. and Czuch, A. (1994) Toxicol. Lett., 72, 13-21.
75. Miller, J.A. and Surh, Y.-J. (1994) In Handbook of Pharmacology, Vol. 112, Conjugation-deconjugation reactions in drug metabolism and toxicity (Kauffman, F.C.; Ed.), Springer, Berlin, pp. 429-458.
76. Garay, R.P.; Rosati, C.; Fanous, K.; Allard, M.; Morin, E.; Lamiable, D. and Vistelle, R. (1995) Eur. J. Pharmacol., 274, 175-180.
77. Christrup, L.L. (1997) Acta Anaesthesiol Scand., 41, 116-122.
78. Robel, P. and Baulieu, E. (1994) Trends Endocrinol. Metab., 5, 1-8.
79. Lambert, J.J.; Belelli, D.; Hill-Venning, C. and Peters, J.A. (1995) Trends Pharmacol. Sci., 16, 295-303.
80. Flood, J.F.; Morley, J.E. and Roberts, E. (1992) Proc. Natl. Acad. Sci. USA, 89, 1567-1571.
81. Li, P.; Rhodes, M.E.; Burke, A.M. and Johnson, D.A. (1997) Life Sci., 60, PL45-PL51.
82. Minami, M.; Kawaguchi, T.; Takendaka, K.; Hamaue, N.; Endo, T.; Hirafuji, M.; Ohno, K.; Hagihara, K. and Parvez, H.S. (1995a) Biogenic. Amines, 11, 469-477.
83. Minami, M.; Terado, M.; Kudo, M.; Endo, T.; Hamaue, N. Hirafuji, M.; Ohno, K.; Itoh, S.; Yoshizawa, I. and Parvez, H.S. (1995) Biogenic. Amines, 11, 487-504.
84. Roberts, K.D. (1987) J. Steroid Biochem., 27, 337-341.
85. Littlewood, J.; Glover, V. and Sandler, M. (1985) Br. J. Clin. Pharmacol., 19, 275-278.
86. Gibb, C.; Glover, V. and Sandler, M. (1987) Biochem. Pharmacol., 36, 2325-2330.
87. Bamforth, K.J.; Jones, A.L.; Roberts, R.C. and Coughtrie, M.W.H. (1993) Biochem. Pharmacol., 46, 1713-1720.
88. Coughtrie, M.W.H. and Johnston, L.E. (2001) Drug Metab. Dispos., 29, 522-528.
89. De Santi, C.; Pietrabissa, A.; Mosca, F.; Rane, A. and Pacifici, G.M. (2002) Xenobiotica, 32, 363-368.
90. Marchetti, F.; De Santi, C.; Vietri, M.; Pietrabissa, A.; Spisni, R.; Mosca, F. and Pacifici, G.M. (2001) Xenobiotica, 31, 841-847.
91. Eaton, E.A.; Walle, U.K.; Lewis, A.J.; Hudson, T.; Wilson, A.A. and Walle, T. (1996) Drug Metab. Dispos., 24, 232-237.
92. Walle, T.; Eaton, W.A. and Walle, U.K. (1995) Biochem. Pharmacol., 50, 731-734.
93. Shimizu, M.; Ohta, K.; Matsumoto, Y.; Fukuoka, M.; Ohno, Y. and Ozawa, S. (2002) Toxicol. in vitro, 16, 549-556.
94. Ohkimoto, K.; Liu, M.-Y.; Suiko, M.; Sakaibara, Y. and Liu, M.-C. (2004) Chem. Biol. Interact, 147, 1-7.
95. Mesia-Vela, S. and Kauffman, F.C. (2003) Xenobiotica, 33, 1211-1220.
96. Harborne, J.B.; Mabry, T.J. and Griffiths, L.A. (1982) J. Biochem., 14, 692-694.
97. Hakkinen, S.H.; Karenlampi, S.O.; Heinonen, I.M.; Mykkanen, H.M. and Torrenen, A.R. (1999) J. Agric. Food Chem., 47, 2274-2279.
98. Goldberg, D.M.; Tsang, E.; Karumanchiri, A.; Diamandis, E.P.; Soleas, G. and Ng, E. (1996) Anal. Chem., 68, 1688-1694.
99. Hollman, P.C.H.; Van Trijp, J.M.P.; Buysman, M.N.C.P.; Gaag, M.S.V.D.; Mengelers, M.J.B.; De Vries, J.H.M. and Katan, M.B. (1997) FEBS Lett., 418, 152-156.
100. De Santi, C.; Pietrabissa, A.; Spisni, R.; Mosca, F. and Pacifici, G.M. (2000) Xenobiotica, 30, 857-866.
101. Morimitsu, Y.; Sugihara, N. and Furuno, K. (2004) Biol. Pharm. Bull., 27, 714-717.
102. Ghazali, R.A. and Waring, R.H. (1999) Life Sci., 65, 1625-1632.
103. Ebmeier, C.C. and Anderson, R.J. (2004) J. Clin. Endocrinol Metab., 89, 5597-5605.
104. Sundström, G.; Hutzinger, O. and Safe, S. (1976) Chemosphere, 5, 267-298.
105. Jansson, B.; Jensen, S.; Olsson, M.; Renberg, L.; Sundström, G. and Vaz, R. (1975) Ambio., 4, 93-97.
106. Kester, M.H.A.; Bulduk, S.; Tibboel, D.; Meinl, W.; Glatt, H.; Falany, C.N.; Coughtrie, M.W.H.; Bergman, A.; Safe, S.H.; Kuiper, G.G.J.M.; Schuur, A.G.; Brouwer, A. and Visser, T.J. (2000) Endocrinology, 141, 1897-1900.
107. Schuur, A.G.; Brouwer, A.; Bergman, A.; Coughtrie, M.W.H. and Visser, T.J. (1998) Chem. Biol. Interact, 109, 293-297.
108. Schuur, A.G.; Legger, F.F.; Van Meeteren, M.E.; Moonen, M.J.H.; Van Leeuwen-Bol, I.; Bergman, A.; Visser, T.J. and Brouwer, A. (1998) Chem. Res. Toxicol., 11, 1075-1081.
109. Schuur, A.G.; Van Leeuwen-Bol, I.; Jong, W.M.C.; Bergman, A.; Coughtrie, M.W.H.; Brouwer, A. and Visser, T.J. (1998) Toxicol. Sci., 45, 188-194.
110. van den Hurk, P.; Kubiczak, G.A.; Lehmler, H.-J. and James, M.O. (2002) Environ. Health Perspect., 110, 343-348.
111. Wang, L.Q.; Lehmler, H.-J.; Robertson, L.W.; Falany, C.N. and James, M.O. (2005) Environ. Health Perspect., 113, 680-687.
112. Wang, L.Q. and James, M.O. (2005) in submission.
113. Safe, S.H. (1990) CRC Crit. Rev. Toxicol., 21, 51-88.
114. Kester, M.H.A.; Bulduk, S.; Van Toor, H.; Tibboel, D.; Meinl, W.; Glatt, H.; Falany, C.N.; Coughtrie, M.W.H.; Schuur, A.G.; Brouwer, A. and Visser, T.J. (2002) J. Clin. Endocrinol. Metab., 87, 1142-1150.
115. Mulder, G.J. and Scholtens, E. (1977) Biochem. J., 165, 553-559.
116. Koster, H.; Scholtens, E. and Mulder, G.J. (1979) Med. Biol., 57, 340-344.
117. Seah, V.M.Y. and Wong, K.P. (1994) Biochem. Pharmacol., 47, 1743-1749.
118. Lai, C.-C.; Miller, J.A.; Miller, E.C.; Liem, A. (1985) Carcinogenesis, 6, 1037-1045.
119. Meerman, J.H.N.; Sterenborg, H.M. and Mulder, G.J. (1983) Biochem. Pharmacol., 32, 1587-1593.
120. Duffel, M.W. and Jakoby, W.B. (1981) J. Biol. Chem., 256, 11123-11127.
121. Nagata, K.; Ozawa, S.; Miyata, M.; Shimada, M.; Gong, D.W.; Yamazoe, Y. and Kato, R. (1993) J. Biol. Chem., 268, 24720-24725.
122. Aksoy, I.A.; Wood, T.C. and Weinshilboum, R. (1994) Biochem. Biophys. Res. Commun., 200, 1621-1629.
123. Li, X.Y. and Anderson, R.J. (1999) Biochem. Biophys. Res. Commun., 263, 632-639.
124. Raftogianis, R.B.; Wood, T.C. and Weinshilboum R.M. (1999) Biochem. Pharmacol., 58, 605-616.
125. Fujita, K.; Nagata, K.; Yamazaki, T.; Watanabe, E.; Shimada, M. and Yamazoe, Y. (1999) Biol. Pharm. Bull., 22, 446-452.
126. Wang, L.Q.; Falany, C.N. and James, M.O. (2004) Drug Metab. Dispos., 32, 1162-1169.
127. Olea, N.; Pulgar, R.; Perez, P.; Olea-Serrano, F.; Rivas, A.; Novillo-Fertrell, A.; Pedraza, V.; Soto, A.M. and Sonnenschein, C. (1996) Environ. Health Perspect., 104, 298-305.
128. Roy, D.; Palagat, M.; Chen, C.W.; Thomas, R.D.; Colerangle, J.; Atkinson, A. and Yan, Z.J. (1997) J. Toxicol. Environ. Health, 50, 1-29.
129. Rao, S.I. and Duffel, M.W. (1992) Xenobiotica, 22, 247-255.
130. Vietri, M.; De Santi, C.; Pietrabissa, A.; Mosca, F. and Pacifici, G.M. (2000) Eur. J. Clin. Pharmacol., 56, 81-87.
131. Vietri, M.; De Santi, C.; Pietrabissa, A.; Mosca, F. and Pacifici, G.M. (2000) Xenobiotica, 30, 111-116.
132. Vietri, M.; Pietrabissa, A.; Mosca, F.; Rane, A. and Pacifici, G.M. (2001) Xenobiotica, 31, 153-161.
133. Vietri, M.; Pietrabissa, A.; Spisni, R.; Mosca, F. and Pacifici, G.M. (2000) Eur. J. Clin. Pharmacol., 56, 477-479.
134. Vietri, M.; Vaglini, F.; Pietrabissa, A.; Spisni, R.; Mosca, F. and Pacifici, G.M. (2002) Xenobiotica, 32, 587-594.
135. Harris, R.M.; Hawker, R.J.; Langman, M.J.S.; Singh, S. and Waring, R.H. (1998) Gut, 42, 272-275.
136. Neuvonen, P.J. and Kivisto, K.T. (1988) Eur. J. Clin. Pharmacol., 35, 495-501.
137. Anonymous (1998) Drug data handbook, 3rd edn, Adis International, Auckland, pp. 1-52.
138. Benet, L.Z.; Oie, S. and Schwartz, J.B. (1996) in The pharmacological basis of therapeutics (Hardman, J.G.; Limbird, L.E.; Molinoff, P.B.; Ruddon, R.W. and Gilman, A.G. (Eds) 9th edn. McGraw-Hill, New York, pp. 1707-1793.
139. Viani, A.; Rizzo, G.; Carrai, M.; Pacifici, G.M. (1992) Br. J. Clin. Pharmacol., 33, 299-304.
140. Bamforth, K.J.; Dalgliesh, K. and Coughtrie, M.W.H. (1992) Arch. Pharm. Res., 21, 475-477.
141. Yasuda, S.; Suiko, M. and Liu, M.C. (2005) J. Biochem., 137, 401-406.
142. Levy, G. and Yamada, H. (1971) J. Pharm. Sci., 60, 215-221.
143. O'Neil, W.M.; Pezzullo, J.C.; di Grolamo, A.; Tsoukas, C.M. and Wainer, I.W. (1999) Br. J. Clin. Pharmacol., 48, 811-818.
144. Cui, D.; Booth-Genthe, C.L.; Carlini, E.; Carr, B. and Schrag, M.L. (2004) Drug Metab. Dispos., 32, 1260-1264.
145. Lanza-Jakoby, S.; Miller, S.; Flynn, J.; Gallatig, K.; Daskalakis, C.; Masferrer, J.L.; Zweifel, B.S.; Sembhi, H. and Russo I.H. (2003) Cancer Epidemiol. Biomar. Prev., 12, 1486-1491.
146. Basu, G.D.; Pathangey L.B.; Tinder, T.L.; Lagioia, M.; Gendler, S.J. and Mukherjee, P. (2004) Mol. Cancer Res., 2, 632-642.
147. Zhang, S.; Lawso, K.A.; Simmons-Menchaca, M.; Sun, L.; Sanders, B.G. and K. Kline (2004) Breast Cancer Res. Treat., 87, 111-121.
148. Levitt, R.J.; Buckley, J.; Blouin, M.J.; Schaub, B.; Triche, T.J. and Pollak M. (2004) Biochem. Biophys. Res. Commun., 316, 421-428.
149. Guastalla, J.P.; Bachelot, T. and Ray-Coquard, I. (2004) Bull. Cancer, 91, 99-108.
150. Wang, L.Q. and James, M.O. (2005) J. Steroid Biochem. Mol. Biol., 96, 367-374.
151. Rens-Domiano, S.S. and Roth, J.A. (1987) J. Neurochem., 48, 1411-1415.
152. Horwitz, J.P.; Misra, R.S.; Rozhin, J.; Neenan, J.P.; Huo, A.; Godefroi, V.C.; Philips, K.D.; Chung, H.L.; Butke, G. and Brooks, S.C. (1978) Biochim. Biophys. Acta, 525, 364-372.
153. Whittemore, R.M.; Pearce, L.B. and Roth, J.A. (1986) Arch. Biochem. Biophys., 249, 464-471.
154. Radzicka, A. and Wolfenden, R. (1995) Methods Enzymol., 249, 284-312.
155. Armstrong, J.I.; Ge, X.; Verdugo, D.E.; Winans, K.A.; Leary, J.A. and Bertozzi, C.R. (2001) Org. Lett., 3, 2657-2660.
156. Iyer, V.K.; Butler, W.B.; Horwitz, J.P.; Rozhin, J.; Brooks, S.C.; Corombos, J. and Kessel, D. (1983) J. Med. Chem., 26, 162-166.
157. Armstrong, J.I.; Verdugo, D.E. and Bertozzi, C.R. (2003) J. org. Chem., 68, 170-173.
158. Gray, N.S.; Wodicka, L.; Thunnissen, A.; Norman, T.C.; Kwon, S.J.; Espinoza, F.H.; Morgan, D.O.; Barnes, G.; LeClerc, S.; Meijer, L.; Kim, S.H.; Lockhart, D.J. and Schultz, P.G. (1998) Science, 281, 533-538.
159. Verdugo, D.E.; Cancilla, M.T.; Ge, X.; Gray, N.S.; Chang, Y.T.; Schultz, P.G.; Negishi, M.; Leary, J.A. and Bertozzi, G.R. (2001) J. Med. Chem., 44, 2683-2686.
160. Chapman, E.; Ding, S.; Schultz, P.G. and Wong, C.-H. (2002) J. Am. Chem. Soc., 124, 14524-14525.
161. Burkart, M.D. and Wong, C.-H. (1999) Anal. Biochem., 274, 131-137.
162. Best, M.D.; Brik, A.; Chapman, E.; Lee, L.V.; Cheng, W.-C. and Wong, C.-H. (2004) ChemBioChem., 5, 811-819.
163. Matsui, M.; Takahashi, M. and Homma, H. (1993) Biochem. Pharmacol., 46, 465-470.
164. Matsui, M.; Takahashi, M.; Miwa, Y.; Motoyoshi, Y. and Homma, H. (1995) Biochem. Pharmacol., 49, 739-741.
165. Rao, S.I. and Duffel, M.W. (1991) Drug Metab. Dispos., 19, 543-545.
166. Horwitz, J.P.; Iyer, V.K.; Vardhan, H.B.; Corombos, J. and Brooks, S.C. (1986) J. Med. Chem., 29, 692-698.
167. Bartzatt, R. and Beckmann, J.D. (1994) Biochem. Pharmacol., 47 (11), 2087-2095.
168. Reiter, C.; Mwaluko, G.; Dunnette, J.; Van Loon, J. and Weinshilboum, R. (1983) Naunyn-Schmiedeberg's Arch. Pharmacol., 324, 140-147.
169. Ganguly, T.C.; Krasnykh, V. and Falany, C.N. (1995) Drug Metab. Dispos., 23, 945-950.
170. Barnett, A.C.; Tsvetanov, S.; Gamage, N.; Martin, J.L.; Duggleby, R.G. and McManus, M.E. (2004) J. Biol. Chem., 279, 18799-18805.
171. Zhang, H.; Varmalova, O.; Vargas, F.M.; Falany, C.N. and Leyh, T.S. (1998) J. Biol. Chem., 273, 10888-10892.
172. Ma, B.; Shou, M. and Schrag, M.L. (2003) Drug Metab. Dispos., 31, 1300-1305.
173. Palmer, T. (1995) In Understanding enzymes (Palmer, T., Ed), Fourth edition, Prentice Hall Ellis Horwood, pp. 129-154.
174. Cruickshank, D. and Sansom, L.N. (1993) Eur. J. Pharm. Sci., 1, 41-47.
175. Watabe, T.; Ogura, K.; Okuda, H. and Hiratsuka, A. (1989) In Proceedings of the 2nd International ISSX Meeting, (Kato, R.; Estrabrook, R.W. and Cayen, M.N.; Eds), Taylor & Francis, Kobe, pp. 393-400.
176. Surh, Y.-J.; Laim C.-C.; Miller, J.A. and Miller, E.C. (1987) Biochem. Biophys. Res. Commun., 144, 576-582.
177. Mitchell, J.R.; Jollow, D.J.; Potter, W.Z.; Davis, D.C.; Gillette, J.R. and Brodie, B.B. (1973) J. Pharmacol. Exp. Ther., 187, 185-194.
178. Heubi, J.E.; Barbacci, M.B. and Zimmerman, H.J. (1998) J. Pediatr., 132, 22-27.
179. Loi, C.M.; Alvey, C.W.; Vassos, A.B.; Randinitis, E.J.; Sedman, A. and Koup, J. (1999) J. Clin. Pharmacol., 39, 920-926.
180. Loi, C.M.; Randinitis, E.J.; Vassos, A.B.; Kazierad, D.J.; Koup, J.R. and Sedman, A.J. (1997) J. Clin. Pharmacol., 37, 1114-1120.
181. Kostrubsky, V.E.; Sinclair, J.F.; Ramachandran, V.; Venkataramanan, R.; Wen, Y.H.; Kindt, R.; Galchev, V.; Rose, K.; Sinz, M. and Strom, S.C. (2000) Drug Metab. Dispos., 28, 1192-1197.
182. Ribeiro, O.; Kirkby, C.A.; Hirom, P.C. and Millburn, P. (1986) Adv. Exp. Med. Biol., 197, 833-842.
183. Glatt, H.; Seidel, A.; Ribeiro, O.; Kirkby, C.; Hirom, P.C. and Oesch, F. (1987) Carcinogenesis, 8, 1621-1627.
184. Safe, S.H. (1994) Crit. Rev. Toxicol., 24, 87-149.
185. Kuiper, G.G.J.M.; Lemmen, J.G.; Carlson, B.; Corton, J.C.; Safe, S.H.; Van der Saag, P.T.; Van der Burg, B. and Gustafsson, J.A. (1998) Endocrinology, 139, 4252-4263.
186. Korach, K.S.; Sarver, P.; Chae, K.; McLachlan, J.A. and McKinney, J.D. (1988) Mol. Pharmacol., 33, 120-126.
187. Arulmozhiraja, S.; Shiraishi, F.; Okumura, T.; Iida, M.; Takegami, H.; Edmonds, J.S. and Morita, M. (2005) Toxicol. Sci., 84, 49-62.
188. Loretz, L.J. and Pariza, M.W. (1984) Carcinogenesis, 5, 895-899.
189. Meerman, J.H.N.; Van Doorn, A.B. and Mulder, G.J. (1980) Cancer Res., 40, 3772-3779.
190. Meerman, J.H.N. and Mulder, G.J. (1981) Life Sci., 28, 2361-2365.
191. Monteith, D.K. (1992) Mutat. Res., 282, 253-258.
192. Borchert, P.; Miller, J.A.; Miller, E.C. and Shires, T.K. (1973) Cancer Res., 33, 590-600.
193. Boberg, E.W.; Miller, E.C.; Miller, J.A.; Poland, A. and Liem, A. (1983) Cancer Res., 43, 5163-5173.
194. Randerath, K.; Haglund, R.E.; Phillips, D.H. and Reddy, M.V. (1984) Carcinogenesis, 5, 1613-1622.
195. Daimon, H.; Sawada, S.; Asakura, S. and Sagami, F. (1997/98) Teratog. Carcinog. Mutagen., 17, 327-337.
196. Hoffmann, D.H. and Rathkamp, G. (1968) Beitr. Tabakforsch., 4, 124-134.
197. Lewis, T.R; Ulrich, C.E. and Busey, W.M. (1979) J. Environ. Pathol. Toxicol., 2, 233-249.
198. Fiala, E.S.; Czerniak, R.; Castonguay, A.; Conaway, C.C. and Rivenson, A. (1987) Carcinogenesis, 8, 1947-1949.
199. Andrae, U.; Kreis, P.; Coughtrie, M.W.; Pabel, U.; Menl, W.; Bartsch, I. and Glatt, H. (1999) Mutat. Res., 439, 191-197.
200. Sodum, R.S.; Sohn, O.S.; Nie, G. and Fiala, E.S. (1994) Chem. Res. Toxicol., 7, 344-351.
201. Kreis, P.; Degen, G.H. and Andrae, U. (1998) Mutat. Res., 413, 69-81.
202. Fiala, E.S.; Sodum, R.S.; Hussain, N.S.; Rivenson, A. and Dolan, L. (1995) Toxicology, 99, 89-97.
203. Foth, J. and Degen, G.H. (1991) Arch. Toxicol., 65, 344-347.
204. Back, D.J.; Breckenridge, A.M. and Orme, M.L. (1983) IPPF Med. Bull., 17, 1-2.
205. Back, D.J.; Breckenridge, A.M.; MacIver, M.; Orme, M.L.; Purba, H. and Rowe, P.H. (1981) Br. Med. J. (Clin. Res. Ed.), 282, 1516.
206. De Santi, C.; Pietrabissa, A.; Spisni, R.; Mosca, F. and Pacifici, G.M. (2000) Xenobiotica, 30, 609-617.